Related Experiment Video
Updated: May 13, 2026
Granulocyte-dependent Autoantibody-induced Skin Blistering
Published on: October 12, 2012
Activation of coagulation, anti-coagulation, fibrinolysis and the complement system in patients with urticaria
Huilan Zhu1, Bihua Liang, Runxiang Li
1Guangzhou Institute of Dermatology, Guangzhou, China. zhlhuilan@hotmail.com
Background:
Recently released studies indicate that activation of blood coagulation may be involved in causing urticaria.
Objective:
To evaluate whether or not anticoagulation, fibrinolysis and the complement system are also involved in the pathogenesis of urticaria.
Methods:
Coagulant factors, anticoagulant factors, fibrinolytic markers and complement components were analysed in patients with acute urticaria (AU) and chronic urticaria (CU). Conclusion: The activation of coagulation, anti-coagulation, fibrinolysis and the complement system may be involved in the pathogenesis of urticaria. It also indicates that coagulation conditions in CU patients can recover after antihistamine treatment, but do not immediately return to normal levels directly after administration.
Results:
Plasma levels of activated factor VII (FVIIa) were higher in AU patients (P <0.01) but not significantly different in CU patients (P >0.05), while levels of the thrombin-antithrombin complex (TAT) and prothrombin fragment 1+2 (F1+2) were significantly higher in CU patients (P <0.01). Levels of factor IX (FIX) and tissue factor (TF) were lower in CU patients (P <0.01). Plasma levels of tissue factor pathway inhibitor/activated factor X (TFPI/Xa) were higher in CU patients (P <0.01) but not significantly different in AU patients (P >0.05), whereas levels of thrombomodulin (TM) were lower in CU patients (P <0.01). Plasma levels of D-dimer in AU and CU patients and levels of high molecular weight kininogen (HMWK) in CU patients were increased significantly (P <0.01), while levels of tissue-type plasminogen activator (t-PA) were decreased (P <0.01). Plasma concentrations of C5a in CU patients were superior to those in healthy controls (P <0.01). Serum levels of C4 also increased (P <0.01).
Conclusion:
The activation of coagulation, anti-coagulation, fibrinolysis and the complement urticaria. It also indicates that coagulation conditions in CU patients can recover after antihistamine treatment, but do not immediately return to normal levels directly after administration.
More Related Videos
06:29Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
Published on: January 29, 2014
07:08Assessment of the Anticoagulant and Anti-inflammatory Properties of Endothelial Cells Using 3D Cell Culture and Non-anticoagulated Whole Blood
Published on: September 5, 2017
Related Concept Videos
01:27Complement System
01:20Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
01:19Hypersensitivity Reactions: Immune-Complex Reactions
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
01:05Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
01:09Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...